Prognostic Role of Hypoxia-Inducible Factor-2α Tumor Cell Expression in Cancer Patients: A Meta-Analysis

被引:45
作者
Roig, Eloy Moreno [1 ]
Yaromina, Ala [1 ]
Houben, Ruud [2 ]
Groot, Arjan J. [1 ]
Dubois, Ludwig [1 ]
Vooijs, Marc [1 ]
机构
[1] Maastricht Univ, Dept Radiotherapy MAASTRO, GROW Sch Dev Biol & Oncol, Maastricht, Netherlands
[2] MAASTRO Clin, Dept Radiat Oncol, Maastricht, Netherlands
基金
欧洲研究理事会;
关键词
cancer; hypoxia-inducible factor-2; meta-analysis; prognosis; endothelial PAS domain protein-1; ENDOTHELIAL GROWTH-FACTOR; PAS DOMAIN PROTEIN-1; NECK-CANCER; HEPATOCELLULAR-CARCINOMA; HIF-2-ALPHA EXPRESSION; TRANSCRIPTION FACTOR; POOR-PROGNOSIS; BREAST-CANCER; PANCREATIC-CANCER; FACTOR; 1-ALPHA;
D O I
10.3389/fonc.2018.00224
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypoxia-inducible factor-2 alpha (HIF-2 alpha) plays an important role in tumor progression and metastasis. A number of studies have evaluated the correlation between HIF-2 alpha overexpression and clinical outcome in cancer patients but yielded inconsistent results. To comprehensively and quantitatively summarize the evidence on the capability of HIF-2 alpha to predict the prognosis of cancer patients with solid tumors, a meta-analysis was carried out. Renal cell carcinoma (CC-RCC) was separately analyzed due to an alternative mechanism of regulation. Systematic literature searches were performed in PubMed and Embase databases for relevant original articles until February 2018. Forty-nine studies with 6,052 patients were included in this study. The pooled hazard ratios (HRs) with corresponding confidence intervals were calculated to assess the prognostic value of HIF-2 alpha protein expression in tumor cells. The meta-analysis revealed strong significant negative associations between HIF-2 alpha expression and five endpoints: overall survival [HR = 1.69, 95% confidence interval (95% CI) 1.39-2.06], disease-free survival (HR = 1.87, 95% CI 1.2-2.92), disease-specific survival (HR = 1.57, 95% CI 1.06-2.34), metastasis-free survival (HR = 2.67, 95% CI 1.32-5.38), and progression-free survival (HR = 2.18, 95% CI 1.25-3.78). Subgroup analyses revealed similar associations in the majority of tumor sites. Overall, these data demonstrate a negative prognostic role of HIF-2 alpha in patients suffering from different types of solid tumors.
引用
收藏
页数:11
相关论文
共 89 条
[1]   Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression [J].
Abel, E. Jason ;
Bauman, Tyler M. ;
Weiker, Madelyn ;
Shi, Fangfang ;
Downs, Tracy M. ;
Jarrard, David F. ;
Huang, Wei .
HUMAN PATHOLOGY, 2014, 45 (05) :1092-1099
[2]   Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2α [J].
Akeno, N ;
Czyzyk-Krzeska, MF ;
Gross, TS ;
Clemens, TL .
ENDOCRINOLOGY, 2001, 142 (02) :959-962
[3]   HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers [J].
Baba, Yoshifumi ;
Nosho, Katsuhiko ;
Shima, Kaori ;
Irahara, Natsumi ;
Chan, Andrew T. ;
Meyerhardt, Jeffrey A. ;
Chung, Daniel C. ;
Giovannucci, Edward L. ;
Fuchs, Charles S. ;
Ogino, Shuji .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (05) :2292-2301
[4]   Prognostic significance of HIF-2α/EPAS1 expression in hepatocellular carcinoma [J].
Bangoura, Gassimou ;
Liu, Zhi-Su ;
Qian, Qun ;
Jiang, Cong-Qing ;
Yang, Gui-Fan ;
Jing, Sun .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (23) :3176-3182
[5]  
Beasley NJP, 2002, CANCER RES, V59, P67
[6]   bHLH-PAS proteins in cancer [J].
Bersten, David C. ;
Sullivan, Adrienne E. ;
Peet, Daniel J. ;
Whitelaw, Murray L. .
NATURE REVIEWS CANCER, 2013, 13 (12) :827-841
[7]   HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses [J].
Bertout, Jessica A. ;
Majmundar, Amar J. ;
Gordan, John D. ;
Lam, Jennifer C. ;
Ditsworth, Dara ;
Keith, Brian ;
Brown, Eric J. ;
Nathanson, Katherine L. ;
Simon, M. Celeste .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (34) :14391-14396
[8]   CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC [J].
Biswas, Swethajit ;
Charlesworth, Philip J. S. ;
Turner, Gareth D. H. ;
Leek, Russell ;
Thamboo, Thomas P. ;
Campo, Leticia ;
Turley, Helen ;
Dildey, Petra ;
Protheroe, Andrew ;
Cranston, David ;
Gatter, Kevin C. ;
Pezzella, Francesco ;
Harris, Adrian L. .
CARCINOGENESIS, 2012, 33 (09) :1717-1725
[9]   Role of hypoxia-inducible factor (HIF)-1α-versus HIF-2α in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-1, or loss of von Hippel-Lindau function:: Implications for targeting the HIF pathway [J].
Carroll, Veronica A. ;
Ashcroft, Margaret .
CANCER RESEARCH, 2006, 66 (12) :6264-6270
[10]   Association of Elevated HIF-2α Levels with Low Beclin 1 Expression and Poor Prognosis in Patients with Chondrosarcoma [J].
Chen, Changbao ;
Ma, Qingjun ;
Ma, Xinlong ;
Liu, Zhongjun ;
Liu, Xiaoguang .
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (08) :2364-2372